Dr. Deepakbabu Chellapandian
Claim this profileJohns Hopkins All Children's Hospital
Studies Aplastic Anemia
Studies Acute Lymphoblastic Leukemia
7 reported clinical trials
23 drugs studied
Affiliated Hospitals
Clinical Trials Deepakbabu Chellapandian is currently running
Reduced Intensity BMT
for Solid Cancer
The purpose of this study is to see if giving reduced intensity chemotherapy, haploidentical bone marrow, post-transplant cyclophosphamide and shortened duration tacrolimus is safe and feasible for patients with very high-risk solid tumors.
Recruiting1 award Phase 228 criteria
IST + BMT
for Aplastic Anemia
Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a matched sibling (brother or sister), or family donor is a bone marrow transplant. Patients without a matched family donor normally are treated with immune suppressive therapy (IST). Match unrelated donor (URD) bone marrow transplant (BMT) is used as a secondary treatment in patients who did not get better with IST, had their disease come back, or a new worse disease replaced it (like leukemia). This trial will compare time from randomization to failure of treatment or death from any cause of IST versus URD BMT when used as initial therapy to treat SAA. The trial will also assess whether health-related quality of life and early markers of fertility differ between those randomized to URD BMT or IST, as well as assess the presence of marrow failure-related genes and presence of gene mutations associated with MDS or leukemia and the change in gene signatures after treatment in both study arms. This study treatment does not include any investigational drugs. The medicines and procedures in this study are standard for treatment of SAA.
Recruiting2 awards Phase 3
More about Deepakbabu Chellapandian
Clinical Trial Related11 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Deepakbabu Chellapandian has experience with
- Methotrexate
- Cyclophosphamide
- Fludarabine
- Prednisone
- Mercaptopurine
- Cytosine Arabinoside
Breakdown of trials Deepakbabu Chellapandian has run
Aplastic Anemia
Acute Lymphoblastic Leukemia
Leukemia
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepakbabu Chellapandian specialize in?
Deepakbabu Chellapandian focuses on Aplastic Anemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Aplastic Anemia has involved treating patients, or patients who are undergoing treatment.
Is Deepakbabu Chellapandian currently recruiting for clinical trials?
Yes, Deepakbabu Chellapandian is currently recruiting for 5 clinical trials in Saint Petersburg Florida. If you're interested in participating, you should apply.
Are there any treatments that Deepakbabu Chellapandian has studied deeply?
Yes, Deepakbabu Chellapandian has studied treatments such as Methotrexate, Cyclophosphamide, Fludarabine.
What is the best way to schedule an appointment with Deepakbabu Chellapandian?
Apply for one of the trials that Deepakbabu Chellapandian is conducting.
What is the office address of Deepakbabu Chellapandian?
The office of Deepakbabu Chellapandian is located at: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida 33701 United States. This is the address for their practice at the Johns Hopkins All Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.